Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxy-G34 in breast cancer
NCT00501332Phase 2Unknown
- Sponsor
- Maxygen
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of MAXY-G34 in chemotherapy-induced neutropenia (CIN), sponsored by Maxygen. Status: unknown.
02
Drugs
MAXY-G34
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT00501332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501332.